As of 2026-10-08, the Intrinsic Value of Fulcrum Therapeutics Inc (FULC) is -4.29 USD. This FULC valuation is based on the model Peter Lynch Fair Value. With the current market price of 3.67 USD, the upside of Fulcrum Therapeutics Inc is -217.01%.
Based on its market price of 3.67 USD and our intrinsic valuation, Fulcrum Therapeutics Inc (FULC) is overvalued by 217.01%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.29 - -4.29 | -4.29 | -217.01% |
| P/E | (6.99) - (14.58) | (10.78) | -393.7% |
| DDM - Stable | (7.15) - (20.67) | (13.91) | -479.1% |
| DDM - Multi | (8.53) - (19.34) | (11.86) | -423.1% |
| Market Cap (mil) | 244.53 |
| Beta | 0.98 |
| Outstanding shares (mil) | 66.63 |
| Enterprise Value (mil) | 196.07 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.07% |
| Cost of Debt | 5.00% |
| WACC | 6.87% |